Elite Pharmaceuticals, Inc. Proceeds from Issuance of Debt
Elite Pharmaceuticals, Inc. (ELTP) reported Proceeds from Issuance of Debt of $415.50 thousand for the 9-month period ending 2013-12-31, per its 10-Q filed 2014-02-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2014-02-14
- Elite Pharmaceuticals, Inc. proceeds from issuance of debt for the quarter ending 2013-12-31 was $0.00.
- Elite Pharmaceuticals, Inc. proceeds from issuance of debt for the quarter ending 2013-09-30 was $0.00.
- Elite Pharmaceuticals, Inc. proceeds from issuance of debt for the quarter ending 2013-06-30 was $415.50K, a 0.00% change year-over-year.
- Elite Pharmaceuticals, Inc. proceeds from issuance of debt for the quarter ending 2013-03-31 was $0.00.
- Elite Pharmaceuticals, Inc. proceeds from issuance of debt for fiscal 2013 was $415.50K.
| Period end | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 9 month | Proceeds from Issuance of Debt 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-14 | $0.00 derived: sum of 2 quarters · filed 2014-02-14 | $415.50K 10-Q · filed 2014-02-14 | $415.50K derived: sum of 4 quarters · filed 2014-02-14 |
| 2013-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-14 | $415.50K 10-Q · filed 2013-11-14 | $415.50K derived: sum of 3 quarters · filed 2013-11-14 | $415.50K derived: sum of 4 quarters · filed 2013-11-14 |
| 2013-06-30 | $415.50K 10-Q · filed 2013-08-14 | $415.50K derived: sum of 2 quarters · filed 2013-08-14 | $415.50K derived: sum of 3 quarters · filed 2013-08-14 | $415.50K derived: sum of 4 quarters · filed 2013-08-14 |
| 2013-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21 | $0.00 derived: sum of 2 quarters · filed 2013-06-21 | $0.00 derived: sum of 3 quarters · filed 2013-06-21 | $415.50K 10-K · filed 2013-06-21 |
| 2012-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-14 | $0.00 derived: sum of 2 quarters · filed 2013-02-14 | $415.50K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-14 | $415.50K 10-Q · filed 2012-11-14 | ||
| 2012-06-30 | $415.50K 10-Q · filed 2012-08-14 |